Australian scientists identify cause of rare blood clots from Johnson & Johnson COVID-19 vaccine

ca.news.yahoo.com

Scientists have identified the cause of rare blood clots linked to Johnson & Johnson's COVID-19 vaccine. The clots, known as VITT, occurred when the immune system mistakenly attacked a blood protein after reacting to the adenovirus used in the vaccine. This discovery, made by Australian researchers, can help prevent similar reactions in future adenovirus-vector vaccines.


With a significance score of 4.8, this news ranks in the top 1.7% of today's 28847 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: